•  
  •  
  •  
  •  

2026-04-20 23:10:28

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Billionbrains Garage Ventures (Groww) Reports Strong FY26 Results; Net Profit Climbs to ₹20,830 Million
  • Takyon Networks Ltd receives order worth Rs. 1.94 crore
  • Ravindra Energy Associate 'Energy in Motion' to Deploy 1,000 Electric Heavy-Duty Trucks
  • Oil Green Energy Ltd inks MoU with Numaligarh Refinery Ltd
  • Muthoot Microfin Ltd - Business Updates for Q4FY26, FY2026

Keywords Selected:  ANDA

Research

  • India Inc revenue growth likely moderated to 4-6% in March quarter - CRISIL Market Intelligence and Analytics

Stock Report

  • Lupin Announces the Approval of Dapagliflozin Tablets in the United States
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dapagliflozin Tablets, 5 mg and 10 mg
  • Marksans Pharma Ltd receives USFDA approval for Benzonatate Capsules USP, 100 mg & 200 mg (Rx)
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 12.5 mg
  • Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg
  • Caplin Steriles gets USFDA approval for Sodium Phosphates Injection
  • Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution, 10 mg/mL
  • Alembic Pharmaceuticals gets USFDA nod for generic Parkinson's disease treatment tablets
  • Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%
  • Biocon Pharma Ltd receives approval from USFDA for its ANDA
  • B and A Ltd consolidated Q2FY26 net profit at Rs. 25.49 crores
  • Caplin Steriles Ltd receives USFDA approval for ANDA Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection
  • FDC Ltd receives USFDA approval for ANDA Pilocarpine Hydrochloride Ophthalmic Solutions
  • Caplin Steriles Ltd granted final approval for ANDA Milrinone Lactate in 5% Dextrose Injection by USFDA
  • Lupin receives U.S. FDA approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity
  • Gland Pharma receives approval for Vasopressin in 5% Dextrose RTU Injection
  • Lupin receives approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • J.B. Chemicals & Pharmaceuticals Ltd receives USFDA approval for ANDA Amitriptyline Hydrochloride Tablets
  • Lupin launches Prucalopride tablets in the United States
  • Lupin receives approval from U.S. FDA for Prucalopride Tablets

Latest Post

  • Billionbrains Garage Ventures (Groww) Reports Strong FY26 Results; Net Profit Climbs to ₹20,830 Million
  • Takyon Networks Ltd receives order worth Rs. 1.94 crore
  • Ravindra Energy Associate 'Energy in Motion' to Deploy 1,000 Electric Heavy-Duty Trucks
  • Oil Green Energy Ltd inks MoU with Numaligarh Refinery Ltd
  • Muthoot Microfin Ltd - Business Updates for Q4FY26, FY2026


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025